Hydroxylamine → HCID 86663941, compound
Reaction equation
[NH2:1][OH:2].[NH:3]1[C:11]2[C:6](=[C:7]([C:12]3[N:13]=[C:14]([N:38]4[CH2:43][CH2:42][O:41][CH2:40][CH2:39]4)[C:15]4[S:20][C:19]([CH2:21][N:22]([C:31]([O:33][C:34]([CH3:37])([CH3:36])[CH3:35])=[O:32])[CH2:23][CH2:24][CH2:25][C:26](OCC)=[O:27])=[CH:18][C:16]=4[N:17]=3)[CH:8]=[CH:9][CH:10]=2)[CH:5]=[N:4]1>>[C:34]([O:33][C:31](=[O:32])[N:22]([CH2:21][C:19]1[S:20][C:15]2[C:14]([N:38]3[CH2:39][CH2:40][O:41][CH2:42][CH2:43]3)=[N:13][C:12]([C:7]3[CH:8]=[CH:9][CH:10]=[C:11]4[C:6]=3[CH:5]=[N:4][NH:3]4)=[N:17][C:16]=2[CH:18]=1)[CH2:23][CH2:24][CH2:25][C:26]([NH:1][OH:2])=[O:27])([CH3:36])([CH3:35])[CH3:37]Participants
Procedure
The freshly prepared hydroxylamine solution (6.00 mL) was placed in 50 mL flask. Compound 0405-41 (300 mg, 0.51 mmol) was added to this solution and degassed at room temperature for 30 minutes. The reaction process was monitored by TLC. The mixture was neutralized with dry ice, filtered, and the precipitation was washed with methanol and water to give tert-butyl(2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl(4-(hydroxyamino)-4-oxobutyl)carbamate (267 mg, 91%) as a white solid. LCMS: 568 [M+1]+; 1H NMR (400 MHz, DMSO-d6):δ1.45 (s, 9H), 1.74 (m, 2H), 1.96 (t, J=7.2 Hz, 2H), 3.23 (m, 2H), 3.83 (m, 4H), 4.00 (m, 4H), 7.47 (t, J=8.0 Hz, 1H), 7.50 (s, 1H), 7.67 (d, J=8.0 Hz, 1H), 8.22 (d, J=8.0 Hz, 1H), 8.70 (s, 1H), 8.88 (s, 1H), 10.39 (s, 1H), 13.22 (s, 1H).
Workup
- customdegassed at room temperature for 30 minutes
- filtrationfiltered
- customthe precipitation
- washwas washed with methanol and water
Sources & evidence
- ORD record
- ord-7b9196b567d04b07a23e98aca529e844
- Source dataset
- uspto-grants-2013_02
- Patent number
- US08367663B2
Reaction notes
Loading…